Search for: "Teva Pharmaceuticals" Results 421 - 440 of 1,423
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Oct 2017, 8:15 am by Gene Quinn
Bryson of the United States Federal District Court for the Eastern District of Texas found that Allergan's RESTASIS® patents were infringed by Teva Pharmaceuticals USA, but that Teva had demonstrated invalidity of those patents by clear and convincing evidence... [read post]
29 Sep 2017, 8:43 am by Kevin S. Little
According to the press release, the following companies are under investigation: Teva, Allergan, Endo, Janssen, Purdue Pharma. [read post]
29 Sep 2017, 8:43 am by Kevin S. Little
According to the press release, the following companies are under investigation: Teva, Allergan, Endo, Janssen, Purdue Pharma. [read post]
24 Sep 2017, 5:04 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc. [read post]
22 Sep 2017, 7:20 am by Altman & Altman
In May 2017, Teva Pharmaceuticals initiated a recall of its schizophrenia drug, Paliperidone. [read post]
8 Sep 2017, 5:07 am by Lindsay Offutt
Filed in the First Judicial District Court for Santa Fe County [official website], the lawsuit claims that major opioid manufacturers, including Purdue Pharma, Johnson and Johnson, Endo Health Solutions, Teva Pharmaceutical Industries and Actavis [corporate websites], falsely represented and downplayed the highly addictive nature of the... [read post]
27 Aug 2017, 10:01 pm by Barry Barnett
Pay-for-delay Listen up, direct purchasers of pharmaceuticals. [read post]
27 Aug 2017, 10:01 pm by Barry Barnett
Pay-for-delay Listen up, direct purchasers of pharmaceuticals. [read post]
11 Aug 2017, 9:09 am by Rachel Sandler
Teva Pharmaceuticals, suggests the court will not impose a secret commercial use or secret sale exception to the public use and on sale bars.[26] In Helsinn Healthcare, the Federal Circuit recognized that “such floor statements are typically not reliable indicators of congressional intent. [read post]
20 Jul 2017, 12:47 pm by George L. Kanabe
  On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
20 Jul 2017, 12:47 pm by George L. Kanabe
  On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
5 Jul 2017, 1:45 pm by Associated Press
The suit names Purdue Pharma, Endo Health Solutions, Teva Pharmaceutical Industries and subsidiary Cephalon, Johnson & Johnson and subsidiary Janssen Pharmaceuticals and Allergan. [read post]
26 Jun 2017, 7:51 am by Gene Quinn
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the existence of the sale is public, the details of the invention need not be publicly disclosed in the terms of sale” for the sale to be invalidating. [read post]
25 Jun 2017, 9:25 pm by Patent Docs
District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc., USA and Teva Pharmaceuticals USA, Inc. to a Report and Recommendation issued by Magistrate Judge Burke and adopted the Report. [read post]
21 Jun 2017, 3:30 am by Eric B. Meyer
Teva Pharmaceuticals (opinion here) [Spoiler Alert: Not very] A tale of two managers But, I’ll share the facts with you anyway. [read post]
13 Jun 2017, 12:00 pm by Sheppard Mullin
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm by Daniel Taskalis
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]